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Abstract 
Objective: To assess the prognostic value of low-dose 64-slice coronary CT 
angiography (CCTA) using prospective electrocardiogram (ECG) triggering in a 
patient population with known or suspected coronary artery disease (CAD). 
Design: Longitudinal follow-up study. 
Setting: Tertiary referral cardiac imaging centre. 
Patients: 405 consecutive patients who were referred for evaluation of CAD by 
CCTA. 
Methods: The presence, distribution and severity of coronary lesions (non-
obstructive < 50% versus obstructive ≥ 50% luminal narrowing) were recorded by 
low-dose prospective ECG triggered CCTA for each patient. The prognostic value of 
low-dose CCTA to predict major adverse cardiac events (MACE), defined as cardiac 
death, non-fatal myocardial infarction (MI), or the need for revascularization, was 
assessed using multivariate Cox regression analysis.  Each individual was followed-
up by telephone interviews and/or on the basis of clinical records. Thirty-eight early 
revascularized patients were excluded from outcome analysis. 
Results: Completely normal coronary arteries were documented in 171 patients 
(47%), while exclusively non-obstructive lesions were found in 66 (18%), and 
obstructive coronary lesions were diagnosed in 130 patients (35%). A mean follow-up 
of 47±16 weeks was obtained. The first-year event rate was 0% in patients with 
normal coronary arteries on CCTA but increased to 3% and 26% in patients with non-
obstructive and obstructive coronary artery lesions, respectively. In multivariate Cox 
regression analysis, significant predictors of events were the presence of obstructive 
or any coronary lesions. Mean effective radiation dose was 1.8±0.6mSv. 





The advent of multislice coronary computed tomography angiography (CCTA) has 
provided clinicians with a promising tool for the noninvasive assessment of coronary 
artery disease (CAD). While the excellent diagnostic accuracy1 and prognostic 
performance2-8 of CCTA have been established, radiation dose exposure has 
remained an intensely discussed issue and may have in part prevented the 
widespread use of CCTA in daily clinical routine so far. Early studies with 
conventional spiral CCTA have reported radiation dose exposures over 20mSv9 and 
the introduction of electrocardiographic (ECG) tube current modulation has reduced 
radiation exposure below 9mSv.10 The recently introduced scanning protocol using 
prospective ECG triggering,11, 12 however, represents a breakthrough with regard to 
radiation dose reduction in CCTA. In fact, studies using prospectively ECG triggered 
CCTA have reported radiation doses around 2mSv11 and below,13 which proved 
substantially lower than those obtained from diagnostic invasive coronary 
angiography (CA) in the first head-to-head comparison.14 On top of feasibility,11, 12 
accuracy of prospectively triggered CCTA has been reported.15 However, its 
prognostic value in an outpatient clinical setting has not yet been established. 
Therefore, we sought to assess the prognostic performance of 64-slice CCTA at 




Study protocol and patient selection 
This is an observational, retrospective, non-blinded, single-centre follow-up study. 
We enrolled consecutive patients who underwent a low-dose CCTA (using 
prospective ECG triggering) for evaluation of suspected or known CAD in the 
absence of any of the commonly accepted exclusion criteria applied to full-dose 
spiral CCTA.16 Thus, none of these patients had irregular heartbeat, known allergy to 
iodinated contrast agent, contraindications for beta-blocking drugs, renal insufficiency 
(serum creatinin > 150µmol/l), inability to follow breath hold commands or failure to 
reach a target heart rate (HR) below 65bpm prior to scanning despite intravenous 
administration of metoprolol. 
Baseline demographic variables, including cardiac risk factors were surveyed at 
the time of admission. Furthermore, previous cardiac symptoms (angina pectoris, 
atypical chest pain or dyspnoea) were assessed and the current medication and any 
history of prior cardiac events (myocardial infarction [MI], percutaneous coronary 
intervention [PCI] or coronary artery bypass graft [CABG]) as well as previous 
abnormal test results (pathological ECG, treadmill test or echocardiography) were 
extracted from physician records within one month of CCTA. 
Follow-up data were obtained from telephone interviews with every patient, if 
possible. Additionally, electronic medical records were retrospectively screened for 
clinical cardiac events. Primary endpoints were major adverse cardiac events 
(MACE), defined as the occurrence of cardiac death, non-fatal MI, or 
revascularization (PCI or CABG). Cardiac death was defined as death caused by 
acute MI, ventricular arrhythmias, or refractory heart failure. Non-fatal MI was defined 
on the basis of biomarkers, ECG and symptoms of ischaemia.17 In one patient where 
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multiple events occurred, the first event was included in the analysis. All patients with 
revascularization procedures within the first 6 weeks were excluded because during 
this period revascularization could potentially be directly triggered by the CCTA 
result, which would introduce a confounder between diagnostic and prognostic value. 
The protocol was approved by the institutional review board and each patient 
provided written informed consent. 
 
CCTA data acquisition and post-processing 
Intravenous metoprolol (Beloc, AstraZeneca) up to a maximum dose of 30mg was 
administered if necessary in order to achieve a target HR below 65bpm. All patients 
additionally received a single dose of 2.5mg sublingual isosorbiddinitrate (Isoket, 
Schwarz Pharma) prior to scanning on a LightSpeed VCT XT scanner (GE 
Healthcare) using prospective ECG triggering with the following scanning parameters 
as previously reported11 and validated:15 slice acquisition 64 × 0.625mm, smallest x-
ray window at 75% of the RR-cycle, z-coverage 40mm with an increment of 35mm, 
gantry rotation time 350ms, body mass index (BMI)-adapted tube voltage and 
current18 and an overall z-coverage of 11 to 25cm. Image acquisition with 75±12ml 
contrast agent (Visipaque 320, GE Healthcare) was initiated 4 seconds after the 
signal density reached a visually detectable threshold in the ascending aorta (bolus 
tracking).  
 
Assessement of image quality and coronary lesions 
Coronary arteries were subdivided into 16 segments according to a modified model 
proposed by the American Heart Association19 with the intermediate artery being 
defined as segment 16, if present.  
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Interpretation was performed on axial source images and multiplanar curved 
reformations. Segments with doubling or discontinuity of the vessel or non-
differentiable structures (no clear delineation between vessel and surrounding tissue) 
were classified as non-evaluative. If a coronary artery segment was non-evaluative, 
the segment was scored similarly to the most proximal segment which was 
evaluable.2 Thus, all segments were scored in all patients, irrespective of image 
quality. 
Non-obstructive coronary lesions were defined as plaques of an area of equal to or 
greater than 1mm2 in orthogonal reconstructions within and/or adjacent to the vessel 
lumen, not belonging to surrounding tissue. An obstructive lesion was defined as a 
stenosis with a visual luminal diameter narrowing of equal or greater than 50%. 
 
Effective radiation dose estimation 
Values for the effective radiation dose for CCTA were estimated as the product of the 
dose-length product (DLP) multiplied by a conversion coefficient for the chest. 
Among the various factors suggested by the European Working Group for Guidelines 
on Quality Criteria in Computed Tomography9 we chose 0.014mSv/mGycm as 
suggested and used in several large multicenter studies on CCTA radiation dose9, 20 
to ensure comparability of the latter with our results. 
 
Statistical analysis 
We used SPSS 17.0 (SPSS Inc.) for all statistical analysis. Categorical variables are 
presented as frequencies and continuous variables as mean ± one standard 
deviation (SD). Variables were compared with chi-square statistics or Fisher’s exact 
test for categoric variables and by Wilcoxon-Mann-Whitney test or independent 
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samples t-test for continuous variables. Follow-up data were analyzed by obtaining 
cumulative event rates for MACE as a function over time using the Kaplan-Meier 
function. Event free survival curves were compared using log-rank test. To assess 
the influence of CCTA findings on clinical endpoints, univariate Cox regression was 
used. Additionally, stepwise forward multivariate Cox regression was applied to 
identify possible independent predictors with p < 0.10 on univariate analysis. The 
regression results are presented as hazard ratios and their confidence intervals (CI). 




Low-dose CCTA with prospective ECG-triggering was performed in 434 patients who 
were enrolled in the present outcome study. Twenty-nine patients (6.7%) were lost to 
follow-up due to invalid contact information (n = 18), refusal to provide follow-up data 
(n = 1), or migration to a foreign country (n = 10).  
Thirty-eight patients that underwent early revascularization (i.e. within 6 weeks 
after CCTA was performed) were excluded. Thus, final outcome analysis was 
performed in 367 patients. Baseline characteristics are provided in Table 1. 
 
Table 1 Patient baseline characteristics (n = 367) 
Male gender (%)  61 
Age (years)   
 Mean ± SD  59 ± 12  
 Range  13 – 85 
BMI (kg / m2)   
 Mean ± SD  26 ± 5 
 Range  18 – 46 
Framingham risk score (%)   
 Low  77 
 Intermediate  15 
 High  8 
Cardiovascular risk factors (%)   
 Obesity (BMI > 30 kg / m2)  16 
 Smoking  35 
 Diabetes  10 
 Hypertension  54 
 Dyslipidaemia  46 
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 Positive family history  40 
Clinical symptoms (%)   
 Typical angina pectoris  12 
 Atypical angina pectoris  48 
 Dyspnoea  13 
 Asymptomatic  27 
Abnormal test results prior to referral (%)   
 Electrocardiogram  10 
 Treadmill test  18 
 Echocardiography  1 
Previous cardiac events (%)   
 Myocardial infarction  4 
 PCI  7 
 CABG  2 
SD = standard deviation, BMI = body mass index, PCI = 




CCTA image quality and findings 
In 367 patients, a total of 5023 coronary artery segments (of theoretically 5872 
segments in 367 patients with 16 segments) were evaluated. There were 645 
segments missing for reasons not related to the technique, i.e. anatomical variants 
(for example the typically missing intermediate artery). 
Normal coronary arteries were documented  in 171 patients (47%). Non-
obstructive coronary lesions were found in 66 (18%), while obstructive lesions were 
diagnosed in 130 patients (35%). 
 
Effective radiation dose estimation 
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Mean DLP for CCTA was 126±43mGycm, resulting in a mean effective radiation 
dose exposure of 1.8±0.6mSv (range: 0.8 – 3.8mSv). 
 
Follow-up results 
During a mean follow-up of 47±16 weeks (range: 26 – 84 weeks), 30 patients (8.2%) 
reached one of the predefined endpoints. These included 1 (0.2%) cardiac death, 3 
(0.7%) non-fatal MI, and 26 (7.1%) revascularization procedures (i.e. 10 CABG and 
16 PCI). For 11 MACE no information was available on whether the event occurred in 
the target vessel with the CCTA finding (1 death without autopsy and 10 patients with 
multivessel disease referred to CABG in whom no single target vessel could be 
defined). For the remaining 16 MACE we could assign (angiographically) 14 to the 
index vessel identified by CCTA, while in 2 patients with angiographic total occlusion 
the neighbouring artery was revascularized, as origin of collaterals serving the target 
territory. A tertile analysis revealed that most MACE occurred in the group of patients 
with the highest amount of coronary lesions, while none occurred in patients in the 
group with the lowest amount of lesions (Figure 1). An additional 38 patients that 
underwent early revascularization were excluded from final outcome analysis. 
 
Survival analysis 
Patients with normal coronary arteries on CCTA had an excellent event-free survival 
as opposed to those with abnormal coronary arteries who had a first-year event rate 
of 20% (p < 0.001) (Figure 2). 
Patients with non-obstructive coronary artery lesions showed an only slightly 
elevated first-year event rate of 3% (p < 0.05 versus patients with normal coronary 
arteries), while patients with obstructive coronary artery lesions presented with a 
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substantially higher event-rate of 26% (p < 0.001 versus patients with normal 
coronary arteries and patients with non-obstructive coronary lesions) (Figure 3 and 
4). 
 
CCTA predictors of events 
The results of univariate Cox regression analysis for clinical characteristics, patients’ 
symptoms, cardiovascular risk factors, and CCTA findings are given in Table 2. The 
presence of an atherosclerosis as evidenced by any non-obstructive or obstructive 
lesion was a strong predictor of MACE (hazard ratio = 74.3, p < 0.001). The presence 
of non-obstructive lesions was a moderate but significant predictor of MACE (hazard 
ratio = 7.1, p = 0.04). Conversely, patients with obstructive CAD (Figure 5) were at 
substantially higher risk for MACE on follow-up (hazard ratio 58.6, p = 0.002). 
 
Table 2 Univariate cox regression proportional hazard analysis (n = 367) 
Variable Hazard ratio (95% CI) p-value 
Clinical characteristics   
 Age 1.04 (1.01 – 1.08) 0.014 
 Male gender 2.11 (0.91 – 4.92) 0.077 
 History of myocardial infarction 2.57 (0.78 – 8.48) 0.082 
 History of PCI  NS 
 History of CABG  NS 
Cardiovascular risk factors   
 Obesity 4.01 (1.96 – 8.55) 0.001 
 Smoking  NS 
 Diabetes 2.33 (0.95 – 5.70) 0.045 
 Hypertension 2.52 (1.12 – 5.67) 0.021 
 Dyslipidaemia 1.98 (0.94 – 4.16) 0.054 
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 Positive family history 3.23 (1.24 – 8.45) 0.011 
Medication   
 Aspirin use 2.38 (1.15 – 4.95) 0.015 
 Betablocker use  NS 
 ACEI/ARB use  NS 
 Statin use  NS 
 Nitrate use 5.99 (2.45 – 14.67) 0.001 
Symptoms   
 Typical angina pectoris 4.59 (2.18 – 9.66) 0.001 
 Atypical chest pain 0.38 (0.17 – 0.86) 0.014 
 Dyspnoea 2.73 (1.21 – 6.13) 0.012 
 Asymptomatic  NS 
Abnormal test results   
 Electrocardiogram  NS 
 Treadmill test 1.98 (0.91 – 4.33) 0.071 
 Echocardiography  NS 
CCTA findings   
 Normal coronary arteries 0.01 (0.01 – 0.26) 0.001 
 Abnormal coronary arteries 74.31 (3.91 – 1413.18) 0.001 
 Number of abnormal segments 1.42 (1.28 – 1.58) 0.001 
 Non-obstructive coronary lesions 7.07 (0.96 – 51.93) 0.037 
 Number of non-obstructive segments  NS 
 Obstructive coronary lesions 58.60 (7.98 – 430.30) 0.002 
 Number of obstructive segments 1.49 (1.35 – 1.64) 0.001 
CI = confidence interval, NS = non significant, PCI = percutaneous coronary 
intervention, CABG = coronary artery bypass graft, ACEI = angiotensin-converting 
enzyme-inhibitor, ARB = angiotensin receptor blocker, CCTA = coronary computed 
tomography angiography 
  
The results of multivariate Cox regression analysis corrected for baseline 
characteristics are given in Table 3. 
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Table 3 Multivariate Cox Proportional Hazard Analysis (n = 367) 
Variable Hazard ratio (95% CI) p-value 
Abnormal coronary arteries 73.97 (3.89 – 1405.84) 0.004 
Number of abnormal segments 1.41 (1.25 – 1.59) 0.001 
Obstructive coronary lesions 50.45 (6.80 – 374.27) 0.001 
Number of obstructive segments 1.52 (1.35 – 1.71) 0.001 





The present data demonstrate the excellent prognostic value of prospectively ECG 
triggered CCTA with a mean effective radiation dose below 2mSv. Absence of 
atherosclerotic findings in CCTA was an excellent predictor of event-free survival. 
Similarly, patients with exclusively non-obstructive lesions had only a slightly reduced 
event-free survival. By contrast, patients with obstructive lesions had a massive 
reduction in event-free survival. Furthermore, the extent of obstructive coronary 
artery disease (i.e. the amount of segments with obstructive lesions) correlated with 
an adverse cardiac outcome. First-year event rate was 0% for patients without any 
evidence of atherosclerosis, 3% for patients with non-obstructive lesions, and 26% 
for patients with obstructive lesions.  
These results are consistent with previous studies reporting up to 40% first year 
event rates in patients with obstructive CAD.2-5 The latter studies, however, used 
spiral CT techniques which are associated with relatively high effective radiation dose 
exposure to the patients ranging between 8 and 25mSv per scan. By contrast, the 
effective radiation dose in the present study averaged 1.8±0.6mSv as we used 
prospective ECG triggering to obtain low-dose CCTA. As radiation safety issues have 
evoked a vivid discussion on the risk to benefit ratio of CCTA,21 reduction of radiation 
dose is essential. This is particularly true for patient populations commonly referred 
for CCTA as their cardiac event risk is typically low. Furthermore, in such a 
population the bars seem to be very high to justify the risk of any diagnostic or 
interventional procedure, as further improvement of prognosis may be difficult to 
achieve. Therefore, the massive reduction in effective radiation dose by introduction 
of prospective ECG triggering is important, as it contributes to shift the risk to benefit 
ratio towards the favourable side of the balance. 
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After demonstrating the feasibility11, 12 and diagnostic accuracy15 and its 
confirmation in a growing body of literature from many different centres,22-25 the 
present study is the first to establish the prognostic performance of low-dose CCTA. 
This refinement, merely the successful reduction of radiation dose exposure by an 
order of magnitude from introduction of spiral CCTA with over 20mSv9 to prospective 
triggered CCTA with 2mSv11, 13 or even scanning in the submillisievert range26 has 
allowed CCTA to rapidly evolve from a premature technique to a reliable and 
valuable clinical tool in daily routine. 
Indeed, repeat CCTA scanning for sensing the transition of atherosclerosis into 
clinically and prognostically relevant CAD or for the monitoring of CAD treatment may 
no longer be considered prohibitive for radiation concerns. 
 
Limitations 
It may be perceived as a potential limitation of the present study that despite the 
above mentioned improvements in CCTA technique, there is still a small percentage 
of patients with non-interpretable coronary segments.12 Latest generation scanners27, 
28
 may contribute to further decreasing non-interpretable studies. 
Furthermore, it may be perceived as a limitation that coronary interventions were 
included as events in the present study. In fact, all previous studies assessing the 
predictive value of spiral CCTA for MACE have included these endpoints. In order to 
ensure meaningful comparability of our results with prospectively triggered CCTA 
versus spiral CCTA we followed the design of these previous studies including all 
revascularization procedures during the entire follow-up period. However, the fact 
that we have – in contrast to previous studies – excluded all patients revascularized 
within the first 6 weeks constitutes a strength of the present study, as this period 
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ensures that all procedures triggered by CCTA itself had been excluded from 
outcome analysis. 
Finally, the CCTA studies were analyzed visually without quantification of 
anatomic lesion severity. However, this corresponds to current clinical practice1 as no 
validated software offering a quantitative algorithm is available as of today.  
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Tertile analysis relating the amount of coronary plaque burden (i.e. the amount of 










Kaplan-Meier cumulative event-free survival curves for patients with normal or 
abnormal (non-obstructive and/or obstructive lesions) coronary arteries. Patients with 
normal coronary arteries on CCTA had an excellent event-free survival as opposed 







Kaplan-Meier cumulative event-free survival curves for patients with normal coronary 
arteries, non-obstructive coronary lesions, and obstructive coronary lesions. Patients 
with non-obstructive coronary artery lesions had a first-year event rate of 3% (p < 
0.05 versus patients with normal coronary arteries), while patients with obstructive 
coronary artery lesions presented with an event-rate of 26% (p < 0.001 versus 





Patients with normal coronary arteries on CCTA had an excellent event-free survival 
as opposed to those with non-obstructive (3% first-year event rate), or obstructive 







CCTA of a seventy-two year old male patient showed multiple non-obstructive 
lesions in all three coronary arteries, illustrated in the multiplanar curved 
reconstructions of the LAD (A), CX (B), and RCA (C), and the volume-rendered 
vessel tree (D). The patient suffered non-fatal myocardial infarction 56 weeks later 
with the invasive coronary angiography (E, LAD and CX; F, RCA) now revealing 
stenoses in all three vessels and the patient being scheduled for emergency 
coronary artery bypass surgery. CCTA acquisition was performed with 85ml of 
contrast agent. Radiation dose was 1.9mSv. 
